The global meningococcal vaccines market was valued at USD 4.2 billion in 2021 and is projected to grow at a CAGR of 9.4% from 2022 to 2031, reaching approximately USD 9.2 billion by the end of 2031. Growth is driven by rising awareness of meningococcal diseases, increasing immunization programs, and strong government initiatives to expand vaccination coverage worldwide.

👉 Get sample market research report copy today@ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1666

High rate of adoption of the meningococcal vaccine can be ascribed to the rise in awareness about the treatment avenues of meningococcal meningitis. This rare disease can lead to serious complications; it has a high fatality rate when left untreated. This type of meningitis is spread through contact with respiratory droplets and may have asymptomatic carriers.

It also causes an infection in the lining of the brain and the spinal cord. An increase in the number of ongoing clinical programs for meningococcal vaccines at various stages of development around the world provides significant opportunities for market participants.

Meningococcal vaccines are used to prevent diseases such as meningitis, meningococcemia, and septicemia caused by N. meningitides. Meningococcal disease, especially meningococcal meningitis, is highly infectious among individuals or communities.

Key Findings of the Market Report

• Based on product type, Conjugate Vaccines continue to lead the market, while Combination Vaccines (MenABCWY) are recording the quickest expansion.
• Quadrivalent Formulations (MenACWY) currently hold the majority of the market share (~53%), but are facing cannibalization risks from new pentavalent options.
• The Pediatric and Adolescent segments remain the primary end-users, though the Travel Immunization segment is growing due to increased global mobility.
• The Public Sector commands approximately 67% of the revenue share, driven by government-funded national immunization programs (NIPs).

Global Market: Growth Drivers

• Rising Incidence of Outbreaks: Growing cases of serogroups W and Y in high-income nations are prompting health authorities to update vaccine recommendations.
• Government Immunization Initiatives: Expanded national programs, particularly in the Middle East and Asia, are ensuring consistent, large-scale demand.
• Development of Multivalent Platforms: New vaccines covering five or more serogroups are simplifying the vaccination process for both providers and patients.
• Increased Public-Private Partnerships: Collaborations between organizations like PATH and manufacturers like the Serum Institute are lowering production costs and improving global access.

👉 Discuss Implications for Your Industry Request Sample Research Report PDF@ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1666

Global Market: Key Players

Market leaders are investing heavily in new manufacturing capacity, such as Merck’s US$ 1 billion facility in North Carolina, to secure global supply chains for the next decade.

• GSK plc (Bexsero, Menveo)
• Pfizer Inc. (Trumenba, Nimenrix, Penbraya)
• Sanofi S.A. (Menactra, MenQuadfi)
• Serum Institute of India Pvt. Ltd. (Men5CV)
• Merck & Co., Inc.
• Walvax Biotechnology Co., Ltd.
• Novartis AG
• Bharat Biotech
• Hualan Biological Engineering Inc.
• Mitsubishi Tanabe Pharma

Global Market: Segmentation

By Vaccine Type

• Conjugate Vaccines
• Polysaccharide Vaccines
• Protein Subunit Vaccines
• Combination Vaccines (MenABCWY)

By Serogroup

• MenACWY
• MenB
• MenC
• MenA
• MenABCWY

By End-User

• Pediatric (Infants & Children)
• Adolescent & Young Adults
• Adults & Geriatric
• Travelers & Military Personnel

👉 To buy this comprehensive market research report, click here to inquire@ https://www.transparencymarketresearch.com/checkout.php?rep_id=1666&ltype=S

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:

Abhishek Budholiya
Transparency Market Research Inc.
State Tower, 90 State Street, Suite 700,
Albany NY – 12207, United States
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Sales Inquiries: sales@transparencymarketresearch.com
Media Inquiries: media@transparencymarketresearch.com